Back to News Release
October 29, 2020

Subaru Corporation Announces Production, Japan Sales and Export Results
for September 2020 and First Half of FYE 2021 (Flash Report)

< September 2020 >

September 2020 Jan-Sep 2020
Units 2020 vs 2019 Units ’20 vs ’19
Domestic production *1
61,460
+4.4% First increase in 6 months
391,672
-13.3%
Overseas production *2
34,771
+32.5% 4th consecutive month of increase
232,811
-14.8%
Global production total
96,231
+13.0% 3rd consecutive month of increase
624,483
-13.8%
Passenger vehicles 6,417 -43.9% 8th consecutive month of decrease 61,394 -28.8%
Mini vehicles 2,026 -47.3% 12th consecutive month of decrease 16,091 -24.9%
Japan sales total 8,443 -44.7% 8th consecutive month of decrease 77,485 -28.0%
Export total *3
53,335
+16.0% 2nd consecutive month of increase
329,391
-8.8%

☆: September record

< Production >

Domestic production: Production of Subaru XV and other models increased.
Overseas production: Production of Outback and other models increased.

< Sales in Japan >

Sales of Levorg and other models decreased at the time of their model changes.

< Exports from Japan >

Shipments of Subaru XV and other models increased.

< April – September 2020 >

April – September 2020
Units 2020 vs 2019
Domestic production *1
220,876
-32.2% First decrease in 2 years
Overseas production *2
133,072
-22.7% 3rd consecutive year of decrease
Global production total
353,948
-28.9% First decrease in 2 years
Passenger vehicles 30,402 -44.8% First decrease in 2 years
Mini vehicles 9,875 -29.6% First decrease in 2 years
Japan sales total 40,277 -41.7% First decrease in 2 years
Export total *3
188,672
-29.0% First decrease in 2 years

< Production >

Domestic production: Production of Forester and other models decreased.
Overseas production: Production of Impreza and other models decreased.

< Sales in Japan >

Sales of Forester and other models decreased.

< Exports from Japan >

Shipments of Forester and other models decreased.

*1 JAMA (Japan Automobile Manufacturers Association Inc.) report basis (CBU)
*2 Local line-off basis
*3 JAMA report basis

Back to News Release